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Site-selective	 Benzoin-type	 Cyclization	 of	 Unsymmetrical	
Dialdoses	 Catalyzed	 by	 N-Heterocyclic	 Carbenes	 for	 Divergent	
Cyclitol	Synthesis	
Bubwoong	Kang,a	Yinli	Wang,a	Satoru	Kuwano,a	Yousuke	Yamaoka,a	Kiyosei	Takasu*a	and	Ken-ichi	
Yamada*a,b
A	 highly	 site-selective	 N-heterocyclic	 carbene	 (NHC)-catalyzed	
benzoin-type	cyclization	of	unsymmetrical	dialdoses	 is	developed	
to	enable	a	divergent	cyclitol	synthesis.	The	choice	of	chiral	NHCs	
and	 protecting	 groups	 affects	 the	 site-selectivity.	 The	 resulting	
inososes	 are	 converted	 into	 epi-,	 muco-	 and	 myo-inositol,	 and	
their	chiral	protected	derivatives	are	formed	in	good	yields.	
Cyclitols, polyhydroxylated cycloalkanes, and their 
derivatives have attracted widespread interest in the fields of 
medicinal, biological and synthetic chemistry 1  due to their 
various biological properties2 as well as their value as building 
blocks.3,4 The most extensively studied are myo-inositol and its 
derivatives, including phosphates because they are ubiquitous 
and are reported to have numerous biological properties. In 
contrast, other stereoisomers (allo-, D-chiro-, L-chiro-, cis-, epi-, 
muco-, neo- and scyllo-inositols) and their derivatives are 
relatively unexplored due to their unavailability in nature. 
Consequently, their potential utilities are unknown. Although 
many methods to synthesize inositol derivatives have been 
reported,1, 5  a new method to supply potentially bioactive 
unprecedented derivatives remains considerably valuable. 
Recently, we developed synthetic methodologies utilizing 
organocatalysts.6 As a part of the study, a new strategy for a 
divergent synthesis of cyclitol derivatives was reported.7 We 
demonstrated that inososes, which are produced by an N-
heterocyclic carbene (NHC)-catalyzed benzoin-type cyclization 
of dialdoses,8 are versatile intermediates for various cyclitol 
derivatives. To selectively obtain inosose via the benzoin-type 
cyclization of an unsymmetrical dialdose such as 1, two factors 
must be controlled: (1) the site-selectivity where one of the two 
formyl groups preferentially reacts with an NHC and is 
converted into a nucleophilic species, or the so-called Breslow 
intermediate, and (2) the π-face-selectivity of the acceptor 
formyl group, which determines the stereochemistry of the 
forming hydroxy group (Scheme 1). 
Scheme	1	Required	selectivity	in	NHC-catalyzed	benzoin-type	cyclization	of	dialdoses	1	
to	give	inososes	2α ,	2β ,	3α 	and	3β .	
Previously we utilized C2-symmetric dialdoses with two 
equivalent formyl groups to avoid issues with site-selectivity, 
and the π-face-selectivity was successfully controlled, realizing 
the selective synthesis of allo-, chiro-, myo-, neo-, scyllo-
inositol derivatives. Herein we report more challenging site- 
and π-face-selective benzoin-type cyclizations of 
unsymmetrical dialdoses 1 to selectively give inosose 2α, 2β, 
3α or 3β, which can be converted to epi-, muco- and myo-
inositol derivatives. To the best of our knowledge, this report 
presents the first examples of  
This is an Accepted Manuscript of an article published by The Royal Society of Chemistry in Chemical Communications,
available online: https://doi.org/10.1039/c7cc01191a
COMMUNICATION	 Journal	Name	
2 	|	J.	Name.,	2012,	00,	1-3	 This	journal	is	©	The	Royal	Society	of	Chemistry	20xx	
Please	do	not	adjust	margins	
Please	do	not	adjust	margins	
	
Figure	1.	Structures	of	NHC	precursors	(NHC·HX).	
Table	1	Benzoin-type	cyclization	of	tetrabenzyl	dialdose	1aa	
	
entry	 NHC·HX	 time/h	 yield/%	 2a:3a	 2a	(α:β) 3a	(α:β)	
1	 4	 20	 51	 41:59	 66:34	 31:69	
2	 5	 9	 59	 69:31	 28:72	 >99:1	
3	 ent-5	 20	 89	 48:52	 73:27	 33:67	
4	 6	 16	 74	 74:26	 68:32	 >99:1	
5	 ent-6	 20	 54	 40:60	 78:22	 42:58	
a	 The	 reaction	 was	 performed	 using	 0.2	 mmol	 1a.	 The	 yields	 and	 ratios	 were	
determined	by	1H	NMR	of	the	crude	products	using	Ph3CH	as	an	internal	standard. 
a highly selective cross benzoin-type reaction 9  between 
aliphatic aldehydes with similar steric bulkiness. 
Initially, we tested several achiral and chiral NHCs 
generated from NHC precursors (Figure 1). A solution of 
tetrabenzyl dialdose 1a (0.2 mmol), which was derived from D-
sorbitol, in toluene (4 mL) was added to a suspension of 4 and 
Cs2CO3 (10 mol% each) in toluene (4 mL). The resulting 
mixture was stirred at rt (Table 1, entry 1). After 20 h, inososes 
2a and 3a were produced in 51% yield with a slight preference 
for 3a (2a:3a = 41:59; site-selectivity). The site-selectivity was 
almost the same as those previously reported for the same NHC 
with different bases and solvents,8a although 3a did not 
epimerize at the α-position under this condition. The epimer 
ratios were moderate for both 2a and 3a (α:β = 66:34 and 31:69, 
respectively).  
Then we tested chiral NHCs derived from 5 and 6 and 
their enantiomers. Although the site- and face-selectivity were 
affected by the utilized NHC, satisfactory site-selectivity was 
not achieved to produce 2a and 3a. At most, a 74:26 selectivity 
was achieved (entries 2–5). 
We speculated that the lack of site- and face-selectivity in 
the reaction of 1a was due to the small difference between the 
steric environment of the two formyl groups and the 
conformational flexibility in the transition states of the 
cyclization, respectively. Therefore, we hypothesized that a 
bulky protective group at the α-position (R1) and a cyclic 
protection at the β-position (R2) would improve the selectivity. 
We tested the NHCs in the reaction of 3,4-O-acetonide 
protected 1b bearing TBDPSO groups at the α-positions (Table 
2). In the reaction of 1b, using less basic NaOAc instead of 
Cs2CO3 was important to prevent undesired side reactions such 
as β-elimination and epimerization. The observed selectivity 
completely differed from that with 1a (Table 1). As expected, 
the site- and face-selectivity generally improved, but it was 
difficult to fully explain the effects of NHCs. The face-
selectivity was strongly influenced by the chirality of the NHCs 
(entries 2 vs 3 and 4 vs 5). In contrast, the site-selectivity 
seemed to be affected by the structures, possibly the bulkiness, 
of the NHCs rather than the chirality (entries 2 and 3 vs. 4 and 
5). Among the tested NHCs, ent-6 showed the best performance 
to preferentially give 2bα with an 84:16 site-selectivity and an 
almost perfect face-selectivity (entry 5).  
The products were unstable on silica gel. Because they 
decomposed and isomerized during purification by column 
chromatography, isolation was accomplished after removal of 
the acetonide. Thus, the reaction of 1b with ent-6 was 
conducted on a 1.5 mmol scale (Scheme 2). After the benzoin-
type reaction, the crude product was hydrolyzed by treatment 
with HF in aqueous acetonitrile to give 2cα in 40% isolated 
yield. Interestingly, the TBDPS groups were inert under 
hydrolysis conditions.  
Unexpectedly, the site-selectivity was reversed when 
dialdose 1d with a carbonate as cyclic protection was utilized to 
give 3dα as the major product (Table 3). Except for the reaction 
with achiral NHC 4 (entry 1), 3dα was formed with high to 
perfect site- and face-selectivities (entries 2–5). Among the 
tested NHCs, the best yield of 67% was produced with ent-6 
(entry 5). After purification by column chromatography using 
DIOL silica gel, 3dα was obtained in 58% yield in a 
diastereomerically pure form. The use of conventional silica gel 
chromatography led to significant decomposition and 
epimerization of the products. 
Table	2	Benzoin-type	cyclization	of	2,5-O-diTBDPS-3,4-O-isopropylidene	dialdose	1ba	
 
entry	 NHC·HX	 time/h	 yield/%	 2b:3b	 2b	(α:β)	 3b	(α:β)	
1	 4	 12	 57	 70:30	 43:57	 >99:1	
2	 5	 12	 48	 21:79	 <1:99	 >99:1	
3	 ent-5	 12	 20	 35:65	 >99:1	 >99:1	
4	 6	 12	 83	 67:33	 85:15	 >99:1	
5	 ent-6	 2.5	 63	 84:16	 >99:1	 >99:1	
a	 The	 reaction	 was	 performed	 using	 0.2	 mmol	 1b.	 The	 yields	 and	 ratios	 were	
determined	by	1H	NMR	of	the	crude	products	using	Ph3CH	as	an	internal	standard.	
	
Scheme	2.	Synthesis	of	2cα	in	diastereomerically	pure	form.	
Table	3	Benzoin-type	cyclization	of	2,5-O-diTBDPS-3,4-O-carbonyl	dialdose	1db	
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entry	 NHC·HX	 time/h	 yield/%	 2d:3d	 2d	(α:β)	 3d	(α:β)	
1	 4	 12	 57	 56:44	 <1:99	 >99:1	
2	 5	 20	 11	 <1:99	 -	 >99:1	
3	 ent-5	 20	 38	 <1:99	 -	 >99:1	
4	 6	 9	 9	 <1:99	 -	 >99:1	
5b	 ent-6	 2	 67	(58)c	 6:94	 <1:99	 93:7	
a	 The	 reaction	 was	 performed	 using	 0.2	 mmol	 1d.	 The	 yields	 and	 ratios	 were	
determined	by	1H	NMR	of	the	crude	products	using	Ph3CH	as	an	internal	standard	
unless	otherwise	noted.	 b	The	 reaction	using	0.5	mmol	1d	 in	 toluene.	 c	 Isolated	
yield	of	3dα	in	the	parentheses.	
Figure 2 depicts the possible transition states for the benzoin-
type cyclization on the basis of the hydrogen bond assisted 6-
membered ring model.7,8a, 10  TS2α, TS2β, TS3α and TS3β were 
probably responsible for the formation of 2α, 2β, 3α and 3β, 
respectively. The transition states to give β-epimers 2β and 3β were 
apparently unstable, especially when bulky substituents were at the 
α-positions due to the increased unfavorable interactions, 1,3-allylic 
strain and 1,3-diaxial repulsion, respectively (TS2β and TS3β). This 
was one reason for the observed face-selectivity in the cyclization. 
As clearly indicated in Table 2, entry 2, the face-selectivity was also 
strongly induced by chirality of NHC. Although it was not easy to 
fully understand the observed opposite site-selectivity between the 
reactions of 1b and 1d, we speculated that one possible reason was 
the steric repulsion between one of the TBDPS groups and the gem-
dimethyl moiety of the acetonide in TS3bα, resulting in the 
unfavorable formation of 3b in the reaction of 1b, while TS3dα 
without such a steric repulsion was preferred over TS2dα in the 
reaction of 1d due to less axial substituents as well as minimum 
allylic strain. 
Scheme 3 depicts the stereoselective reduction of the 
obtained inososes to inositols. Although the reduction of 2cα 
with NaBH4 in methanol suffered from the migration of the 
TBDPS group, the use of BH3·THF gave epi-7c in 80% yield as 
a single diastereomer. The other diastereomer muco-7c was also 
obtained by the β-hydroxy-directed reduction with 
Me4N(AcO)3BH.5d,11  Reduction of 3dα with BH3·THF also 
stereoselectively produced epi-7d in 83% yield. The sense of 
reduction was reversed by using our previously developed 
protocol,7 TES protection followed by reduction with t-
BuNH2·BH3 produced myo-7d in 70% yield as the sole 
diastereomer. The stereochemistries of epi- and muco-7c, and 
epi- and myo-7d were confirmed by conversion into known 
hexaacetates 12 , 13 , 14  in 99%, 93%, 70% and 99% yields, 
respectively. 
In summary, we develop the first highly site-selective 
cross benzoin-type cyclization of unsymmetrical dialdoses to 
give inosose derivatives selectively. The choices of NHCs and 
the protective groups are important to control the site- and face-
selectivity of the cyclization. The resulting inososes can be 
converted into chirally protected derivatives of epi-, muco-, and 
	
Figure	2	Possible	transition	states	TS2α,	TS2β,	TS3α,	TS3β,	TS3bα	and	TS3dα	give	2α,	2β,	3α,	
3β,	3bα	and	3dα,	respectively.	The	Si	represents	a	TBDPS	group.	
	
Scheme	3	Stereodivergent	syntheses	of	epi-,	muco-,	myo-inositols	from	2cα	and	3dα.	
myo-inositol in good yields. 
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